Trial Profile
A Randomized, Sham Controlled, Multicenter, Double-Masked, Phase 2/3 Study Assessing Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 24 Jul 2014
Price :
$35
*
At a glance
- Drugs Betamethasone (Primary)
- Indications Macular degeneration; Retinal vein occlusion
- Focus Therapeutic Use
- Acronyms HIKARI
- Sponsors Santen Pharmaceutical
- 24 Jul 2014 New trial record